Steven Cohen's ADMA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 393,879 shares of ADMA Biologics, Inc. (ADMA) worth $7.18 M, representing 0.01% of the portfolio. First purchased in 2020-Q1, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ADMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2022, adding 1.99 M shares. Largest reduction occurred in Q2 2023, reducing 1.93 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's ADMA Biologics (ADMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADMA Biologics (ADMA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -928,137 | Reduce 70.21% | 393,879 | $18.24 |
| Q3 2025 | +1.32 M | New Buy | 1.32 M | $14.66 |
| Q2 2025 | -847,558 | Sold Out | 0 | $0.00 |
| Q1 2025 | +635,232 | Add 299.18% | 847,558 | $19.84 |
| Q4 2024 | +101,315 | Add 91.27% | 212,326 | $17.15 |
| Q3 2024 | +7,556 | Add 7.30% | 111,011 | $19.99 |
| Q2 2024 | +103,455 | New Buy | 103,455 | $11.18 |
| Q1 2024 | -244,513 | Sold Out | 0 | $0.00 |
| Q4 2023 | +244,513 | New Buy | 244,513 | $4.52 |
| Q2 2023 | -1.93 M | Sold Out | 0 | $0.00 |
| Q1 2023 | -56,524 | Reduce 2.84% | 1.93 M | $3.31 |
| Q4 2022 | +1.99 M | New Buy | 1.99 M | $3.88 |
| Q2 2020 | -250,000 | Sold Out | 0 | $0.00 |
| Q1 2020 | +250,000 | New Buy | 250,000 | $2.88 |
Steven Cohen's ADMA Biologics Investment FAQs
Steven Cohen first purchased ADMA Biologics, Inc. (ADMA) in Q1 2020, acquiring 250,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held ADMA Biologics, Inc. (ADMA) for 14 quarters since Q1 2020.
Steven Cohen's largest addition to ADMA Biologics, Inc. (ADMA) was in Q4 2022, adding 1,991,100 shares worth $7.73 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 393,879 shares of ADMA Biologics, Inc. (ADMA), valued at approximately $7.18 M.
As of the Q4 2025 filing, ADMA Biologics, Inc. (ADMA) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in ADMA Biologics, Inc. (ADMA) was 1,991,100 shares, as reported at the end of Q4 2022.